Patients at Thrombotic Risk: Is Prophylaxis Necessary, Diagnostic & Therapeutic Algorithms, Anticoagulants, Old & New, The Venous Ulcer Initiative (CONG2011-43)

Steps to Successfully Complete This Activity

To participate in this educational activity please follow the steps listed below.

If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.

  1. To begin the activity click the START COURSE button.
  2. Progress through course content by using the NEXT button.
  3. Complete all required items in the course.
  4. Track your progress using the Course Progress menu.
  5. On the final page of the activity a link will be provided to download your certificate.

Target Audience

The content of this activity is designed to meet the needs of the following target audience:  phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.

Learning Objectives

As a result of this activity, the participant should be able to employ the appropriate duration of therapy indications for discontinuing anitcoagulation using newer anticoagulants.

Course summary
Course opens: 
Course expires: 
  • Joseph Caprini, MD, MS, FACS, RVT, discloses that he works with Sanofi, Teleflex, GSK, BI and Covidien.
  • Michael Dalsing, MD, has nothing to disclose.
  • Jawed Fareed, PhD, discloses that he is Consultant to Johnson Johnson , a Member of the Advisory Board of Artisan Pharma, a Consultant to Mitsubushi Pharma, Consultant to Polymedix, and received the Scientific Project Grant from Caynon Pharmaceuticals.
  • Robert Kistner, MD, has nothing to disclose.


The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Discussion of Off-Label Use

Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.

Reproduction Prohibited

Reproduction of this material is not permitted without written permission from the copyright owner.


Please login or register to take this course.